7799 — Heron Neutron Medical Income Statement
0.000.00%
Last trade - 00:00- TWD61.97bn
- TWD51.75bn
- TWD10.31m
Annual income statement for Heron Neutron Medical, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0.238 | 0 | 10.3 |
| Cost of Revenue | ||||
| Gross Profit | 0 | 0.129 | -3.59 | -25.8 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Total Operating Expenses | 87.8 | 130 | 259 | 545 |
| Operating Profit | -87.8 | -130 | -259 | -534 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -86.2 | -126 | -260 | -482 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -86.2 | -126 | -260 | -482 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -86.2 | -126 | -260 | -482 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -86.2 | -126 | -260 | -482 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.618 | -0.907 | -1.98 | -3.31 |
| Dividends per Share |